Swiss Re’s Abbott ABT Stock Holding History

Swiss Re’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$294K	Buy	3,239 +2,848	+728%	+$260K	0.03%	76
2026 Q1	$40.1K	Hold	391	–	–	0.25%	51
2025 Q4	$49K	Buy	+391	New	+$49.8K	﹤0.01%	43

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Swiss Re's ABT Position: Q2 2026 in Review

Swiss Re increased its Abbott (ABT) stake by 728% in Q2 2026, buying an estimated $260K and bringing the position to 3,239 shares worth $294K. The position accounts for 0.03% of the portfolio, ranked #76.

Swiss Re first reported a position in ABT in Q4 2025 and has held it in 3 quarters since. 2,968 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

Swiss Re held 3,239 shares of Abbott worth $294K as of Q2 2026.
Swiss Re bought 2,848 Abbott shares in Q2 2026, an estimated $260K.
Abbott made up 0.03% of Swiss Re's portfolio in Q2 2026, its #76 holding.
Swiss Re first reported a position in Abbott in Q4 2025 and has held it in 3 quarters since.
2,968 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Swiss Re's 13F filing for Q2 2026, filed 11 Aug 2026.